金币
UID176556
帖子
主题
积分25187
注册时间2014-6-6
最后登录1970-1-1
听众
性别保密
|

楼主 |
发表于 2017-8-7 22:21:02
|
显示全部楼层
444. Many comments addressed 211.184(c). Most agreed that an inventory
record and reconciliation for drug product components was appropriate, but
objected to inventory records and reconciliation for drug product containers and
closures. Others contended that inventory records, but not reconciliation, were
also appropriate for drug product containers and closures. Arguments were
primarily that recordkeeping to this extent was unnecessary, burdensome, and not
current practice. Some comments were concerned that extensive records and
reconciliation would be required for packaging materials such as cotton filler
material used in packaging tablets and capsules. Several comments recommended
changes in the proposed language that would clearly require that the inventory
record be sufficient to establish the batch or lot of drug product in which
component, drug product container, and closure are used.
The Commissioner has reconsidered the need for individual inventory records
and reconciliation of the use for components, drug product containers, and
closures. He finds that individual inventory records are necessary to provide
an adequate history regarding the use of components, drug product containers,
and closures. To clarify the intent that such inventory records are intended to
allow for determination as to the batch or lot of drug product associated with
the recorded inventory, the Commissioner is modifying the proposed wording in
this section (211.184(c) and in 211.188(g)).
The Commissioner agrees with the comments that reconciliation of the use of
each lot of drug product container and closure should not be required. Although
there are instances where such reconciliation could be valuable to the drug
manufacturer, it should not be mandatory for all drug products and all drug
manufacturers. The CGMP regulations elsewhere provide considerable control over
the approval and use of drug product containers and closures. Because of the
more critical nature of the ingredients on the other hand, each drug product
component must be inventoried and its use reconciled in order to provide added
assurance of product integrity.
The Commissioner emphasizes that this section does not pertain to all
packaging materials, but only drug product containers and closures. Thus,
individual inventory records for packaging materials such as cotton filler and
package liners are not required under this section, although records regarding
the receipt, examination or testing, and disposition for packaging materials
generally are required in 211.122, particularly in paragraph (c).
|
|